Cargando…
Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity
Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervi...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098275/ https://www.ncbi.nlm.nih.gov/pubmed/21625511 http://dx.doi.org/10.1371/journal.pone.0019993 |
_version_ | 1782203952448667648 |
---|---|
author | Dingle, Kate E. Griffiths, David Didelot, Xavier Evans, Jessica Vaughan, Alison Kachrimanidou, Melina Stoesser, Nicole Jolley, Keith A. Golubchik, Tanya Harding, Rosalind M. Peto, Tim E. Fawley, Warren Walker, A. Sarah Wilcox, Mark Crook, Derrick W. |
author_facet | Dingle, Kate E. Griffiths, David Didelot, Xavier Evans, Jessica Vaughan, Alison Kachrimanidou, Melina Stoesser, Nicole Jolley, Keith A. Golubchik, Tanya Harding, Rosalind M. Peto, Tim E. Fawley, Warren Walker, A. Sarah Wilcox, Mark Crook, Derrick W. |
author_sort | Dingle, Kate E. |
collection | PubMed |
description | Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69 Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5, which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc (at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI, and the evolutionary origins of hypervirulent strains. |
format | Text |
id | pubmed-3098275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30982752011-05-27 Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity Dingle, Kate E. Griffiths, David Didelot, Xavier Evans, Jessica Vaughan, Alison Kachrimanidou, Melina Stoesser, Nicole Jolley, Keith A. Golubchik, Tanya Harding, Rosalind M. Peto, Tim E. Fawley, Warren Walker, A. Sarah Wilcox, Mark Crook, Derrick W. PLoS One Research Article Clostridium difficile infection (CDI) is an important cause of mortality and morbidity in healthcare settings. The major virulence determinants are large clostridial toxins, toxin A (tcdA) and toxin B (tcdB), encoded within the pathogenicity locus (PaLoc). Isolates vary in pathogenicity from hypervirulent PCR-ribotypes 027 and 078 with high mortality, to benign non-toxigenic strains carried asymptomatically. The relative pathogenicity of most toxigenic genotypes is still unclear, but may be influenced by PaLoc genetic variant. This is the largest study of C. difficile molecular epidemiology performed to date, in which a representative collection of recent isolates (n = 1290) from patients with CDI in Oxfordshire, UK, was genotyped by multilocus sequence typing. The population structure was described using NeighborNet and ClonalFrame. Sequence variation within toxin B (tcdB) and its negative regulator (tcdC), was mapped onto the population structure. The 69 Sequence Types (ST) showed evidence for homologous recombination with an effect on genetic diversification four times lower than mutation. Five previously recognised genetic groups or clades persisted, designated 1 to 5, each having a strikingly congruent association with tcdB and tcdC variants. Hypervirulent ST-11 (078) was the only member of clade 5, which was divergent from the other four clades within the MLST loci. However, it was closely related to the other clades within the tcdB and tcdC loci. ST-11 (078) may represent a divergent formerly non-toxigenic strain that acquired the PaLoc (at least) by genetic recombination. This study focused on human clinical isolates collected from a single geographic location, to achieve a uniquely high density of sampling. It sets a baseline of MLST data for future comparative studies investigating genotype virulence potential (using clinical severity data for these isolates), possible reservoirs of human CDI, and the evolutionary origins of hypervirulent strains. Public Library of Science 2011-05-19 /pmc/articles/PMC3098275/ /pubmed/21625511 http://dx.doi.org/10.1371/journal.pone.0019993 Text en Dingle et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Dingle, Kate E. Griffiths, David Didelot, Xavier Evans, Jessica Vaughan, Alison Kachrimanidou, Melina Stoesser, Nicole Jolley, Keith A. Golubchik, Tanya Harding, Rosalind M. Peto, Tim E. Fawley, Warren Walker, A. Sarah Wilcox, Mark Crook, Derrick W. Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity |
title | Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity |
title_full | Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity |
title_fullStr | Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity |
title_full_unstemmed | Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity |
title_short | Clinical Clostridium difficile: Clonality and Pathogenicity Locus Diversity |
title_sort | clinical clostridium difficile: clonality and pathogenicity locus diversity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098275/ https://www.ncbi.nlm.nih.gov/pubmed/21625511 http://dx.doi.org/10.1371/journal.pone.0019993 |
work_keys_str_mv | AT dinglekatee clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT griffithsdavid clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT didelotxavier clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT evansjessica clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT vaughanalison clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT kachrimanidoumelina clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT stoessernicole clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT jolleykeitha clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT golubchiktanya clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT hardingrosalindm clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT petotime clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT fawleywarren clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT walkerasarah clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT wilcoxmark clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity AT crookderrickw clinicalclostridiumdifficileclonalityandpathogenicitylocusdiversity |